KATHERINE MCARTHUR: Open Payments
NPI 1770118747 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 17 payments from 8 companies in 2025. Trend: 2023 $485 · 2024 $536 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $71 |
| Astellas Pharma US Inc | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| PFIZER INC. | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Dexcom, Inc. | 1 | $28 |
| ABIOMED | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: MOUNJARO, Veozah, QULIPTA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, SHINGRIX, GARDASIL 9.
Industry payments across GA — which companies pay providers there.
